To investigate whether FASN signaling is involved in maintaining constitutive PD-L1 overexpression, we took advantage of JIMT-1 cells, a unique model of breast cancer with 100% of the cells being PD-L1 positive without involving an increased PD-L1 gene copy number [67–69]. The gene discussed is FASN; the disease is breast carcinoma.